Add to a list

Inactive Instrument

LOTUS PHARM Stock OTC Bulletin Board

LTUS

US5457151042

Pharmaceuticals

OTC Markets Traded

End-of-day quote OTC Bulletin Board
- ^USD	-

23-07-31	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	MT
21-11-26	Thai oil firm PTT expands pharma business with $475 million Alvogen deal	RE

Lotus Pharmaceuticals Inc is a company mainly engaged in development, manufacture, and sales of pharmaceuticals. The Company produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. The Company's drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The Company operated in two business segment Wholesales segment and Retail segment. The Company's products include Maixin-valsartan capsules for the treatment of hypertension, Muxineye drops for the treatment of glaucoma and Yipubishan-octreotide Acetate Injection solution for the treatment of gastric ulcers. The Company mainly conducts its businesses in the domestic market and overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

Stock markets for all

100% Free Registration

Market Cap	9.74M 8.34M 7.8M 7.14M 13.41M 932M 13.58M 92.19M 35.95M 468M 36.56M 35.76M 1.55B	P/E 2009	3.88x	P/E 2010	4.84x
Enterprise Value	14.38M 12.32M 11.53M 10.55M 19.8M 1.38B 20.07M 136M 53.11M 691M 54M 52.83M 2.29B	EV / Sales 2009	1.02x	EV / Sales 2010	0.95x
Free-Float	99%	Yield 2009 *	-	Yield 2010	-

23-07-31	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	MT
21-11-26	Thai oil firm PTT expands pharma business with $475 million Alvogen deal	RE
21-09-28	Lotus Pharmaceuticals : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund	RE
12-05-16	Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS from LTUSE	CI
12-04-19	Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS.E from LTUS	CI

Dec. 30	Lotus Pharmaceutical Supports Street Medicine Program to Expand Access to Care for Those Most in Need	AQ
25-10-06	Lotus Enters License and Supply Agreement with Adalvo for Semaglutide injection	AQ
25-08-12	Lotus Pharmaceutical Achieves New First-Half Record in Revenue for 2025, While Q2 Impacted by FX and Timing of Lenalidomide Sales	AQ
25-02-21	Lotus announces FDA acceptance of Potential First-to-File ANDA Submission for Voclosporin soft gelatin capsules, a generic equivalent to Lupkynis	AQ
24-11-08	Lotus Achieves Second-Highest Quarterly Performance in Company History with 3Q24 Financial Results	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.08%	-1.43%	+15.99%	+67.26%	47.71B
OTSUKA HOLDINGS CO., LTD.	-3.21%	+1.37%	+52.36%	+125.75%	40.3B
CIPLA LIMITED	-0.40%	-1.23%	-10.08%	+16.08%	12.09B
ZYDUS LIFESCIENCES LIMITED	+1.11%	-1.34%	+13.61%	+71.49%	11.68B
KRKA, D. D.	0.00%	+0.58%	+30.65%	+148.80%	9.19B
GEDEON RICHTER	-0.39%	-0.92%	+19.81%	+39.54%	7.57B
ONO PHARMACEUTICAL CO., LTD.	-1.35%	+0.74%	+47.03%	-11.93%	7.24B
GLENMARK PHARMACEUTICALS LIMITED	-0.64%	-0.02%	+19.42%	+199.06%	6.84B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-5.36%	-6.36%	-36.28%	+18.28%	5.42B
Average	-1.15%	-1.11%	+16.95%	+74.93%	16.45B
Weighted average by Cap.	-1.16%	-0.57%	+24.44%	+83.40%

	2009	2010
Net sales	57.82M 49.53M 46.35M 42.42M 79.62M 5.53B 80.67M 548M 214M 2.78B 217M 212M 9.19B	72.7M 62.27M 58.27M 53.34M 100M 6.96B 101M 688M 268M 3.49B 273M 267M 11.56B
Net income	16.43M 14.08M 13.17M 12.06M 22.63M 1.57B 22.92M 156M 60.68M 790M 61.7M 60.36M 2.61B	14.42M 12.36M 11.56M 10.58M 19.86M 1.38B 20.12M 137M 53.27M 693M 54.16M 52.99M 2.29B
Net Debt	5.29 4.53 4.24 3.88 7.29 506.51 7.39 50.13 19.55 254.44 19.88 19.45 841.6	4.65 3.98 3.72 3.41 6.4 444.6 6.48 44 17.16 223.34 17.45 17.07 738.72

LOTUS PHARM Stock OTC Bulletin Board

Stocks

LTUS

US5457151042

Pharmaceuticals

Valuation: LOTUS PHARM

Latest news : LOTUS PHARM

Press Releases: LOTUS PHARM

Managers and Directors: LOTUS PHARM

Generic Pharmaceuticals

Financials

Company Profile